LONDON (Alliance News) - UK shares are higher at open Thursday, ahead of some US economic data later in the day.<br /><br />B&Q and Screwfix owner <strong>Kingfisher</strong> is leading FTSE 100 fallers, down 5.4%. Despite showing a strong increase in its retail profit for the first quarte Read More

UK AGM, EGM Calendar - Week Ahead

29th May 2014 05:26

UK AGM, EGM Calendar - Week Ahead

28th May 2014 15:04

UK AGM, EGM Calendar - Week Ahead

28th May 2014 05:13

UK AGM, EGM Calendar - Week Ahead

27th May 2014 15:14

Oxford BioMedica Explores Options To Strengthen Financial Position

13th May 2014 12:49

LONDON (Alliance News) - Oxford BioMedica PLC Tuesday said that it has enough cash to sufficiently fund the current level of activities into the third quarter, but it is currently exploring a range of options to strengthen its financial position. The biopharmaceutical company specialising i Read More

Oxford Biomedica Receives GBP2.2 Million Grant For OXB-102 Compound

30th Apr 2014 14:16

LONDON (Alliance News) - Oxford Biomedica said Wednesday it had received a GBP2.2 million grant from the UK government's Technology Strategy Board to help fund a Phase I/II clinical trial of its compound OXB-102 in the treatment of Parkinson's. The compound is delivered with Oxford's LentiV Read More

Oxford Biomedica Regains Rights For RetinoStat After Sanofi Opts Out

29th Apr 2014 09:48

LONDON (Alliance News) - Oxford Biomedica PLC said Tuesday that it will regain the worldwide rights to its treatment for wet age-related macular generation treatment RetinoStat from Sanofi SA, after Sanofi decided not to continue developing the treatment. Sanofi has opted not to continue de Read More

Oxford Biomedica Pretax Loss Widens As Sanofi Collaboration Winds Down

10th Apr 2014 11:13

LONDON (Alliance News) - Oxford Biomedica PLC Thursday posted a widened pretax loss for 2013, as revenue wound down from its long-term collaboration with Sanofi S.A, although the company expressed confidence for 2014 as it looks to shift towards a more self-sustaining model. Oxford Biomedic Read More

FTSE 100 Latest

Value8,809.74

Change53.53